
Myomo MYO
$ 0.83
1.61%
Quarterly report 2025-Q3
added 11-10-2025
Myomo DSO Ratio 2011-2026 | MYO
Annual DSO Ratio Myomo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.704 | 38 | 44.5 | 40.4 | 57.1 | 69.6 | - | 61.2 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.6 | 0.704 | 44.5 |
Quarterly DSO Ratio Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.8 | 55.4 | 39.4 | - | 31 | 25.5 | 49.4 | - | 37.4 | 24.4 | 45.6 | - | 18.3 | 21 | 43.1 | - | 34.8 | 27.9 | 33 | - | 43.8 | 98.3 | 61.1 | - | 63.8 | 44 | 44.3 | - | 57.3 | 55.2 | 99 | - | 55.5 | 88.4 | 86.8 | - | 56.7 | 20.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 99 | 18.3 | 48.9 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
48 | $ 33.79 | 3.62 % | $ 1.5 B | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 7.04 | 2.4 % | $ 505 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Delcath Systems
DCTH
|
54.6 | $ 9.41 | 3.23 % | $ 268 M | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.77 | -1.31 % | $ 131 M | ||
|
Alphatec Holdings
ATEC
|
46.4 | $ 13.4 | 2.29 % | $ 1.92 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.86 | 1.96 % | $ 181 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Electromed
ELMD
|
137 | $ 23.96 | 2.79 % | $ 203 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 257.62 | -11.9 % | $ 7.27 B | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 36.86 | -1.73 % | $ 5.49 K | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
CONMED Corporation
CNMD
|
67 | $ 42.46 | 1.9 % | $ 1.31 B | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 75.21 | 1.46 % | $ 111 B | ||
|
Abbott Laboratories
ABT
|
58.7 | $ 112.23 | 0.68 % | $ 195 B | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
46.1 | $ 13.98 | 7.21 % | $ 378 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
InMode Ltd.
INMD
|
5.36 | $ 14.39 | 0.63 % | $ 1.14 B | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 101.64 | 1.8 % | $ 1.29 B | ||
|
Integer Holdings Corporation
ITGR
|
50.7 | $ 86.59 | 1.44 % | $ 2.91 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Pulmonx Corporation
LUNG
|
54.9 | $ 1.5 | 5.28 % | $ 58.7 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Penumbra
PEN
|
56.4 | $ 340.37 | 0.49 % | $ 13.1 B | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
237 | $ 18.54 | - | $ 122 M | ||
|
Insulet Corporation
PODD
|
40.7 | $ 245.66 | 2.01 % | $ 17.2 B | ||
|
Globus Medical
GMED
|
76.9 | $ 89.1 | 2.16 % | $ 12.1 B | ||
|
Sintx Technologies
SINT
|
70.4 | $ 2.85 | 4.78 % | $ 10.6 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 11.5 | 6.38 % | $ 886 M |